Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Teladoc is a health information services business based in the US. Teladoc stocks (TDOC.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $25.87 – a decrease of 2.85% over the previous week. Teladoc employs 4,335 staff and has a trailing 12-month revenue of around $2.2 billion.
Finder's Pick for
Beginners
Finder's Pick for
Global Trading
Finder's Pick for
Free Trades
| Latest market close | $25.87 |
|---|---|
| 52-week range | $26.12 - $156.82 |
| 50-day moving average | $34.62 |
| 200-day moving average | $53.32 |
| Wall St. target price | $36.40 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-43.42 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $25.87 from 2022-10-03
| 1 week (2022-09-26) | -2.08% |
|---|---|
| 1 month (2022-09-01) | N/A |
| 3 months (2022-07-05) | -33.34% |
| 6 months (2022-04-05) | -63.68% |
| 1 year (2021-10-05) | -79.19% |
|---|---|
| 2 years (2020-10-05) | -88.51% |
| 3 years (2019-10-04) | 66.81 |
| 5 years (2017-10-04) | 34.8 |
Valuing Teladoc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Teladoc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Teladoc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.1 million.
The EBITDA is a measure of a Teladoc's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.2 billion |
|---|---|
| Gross profit TTM | $1.4 billion |
| Return on assets TTM | -1.08% |
| Return on equity TTM | -89.39% |
| Profit margin | 0% |
| Book value | $37.59 |
| Market capitalisation | $4.6 billion |
TTM: trailing 12 months
We're not expecting Teladoc to pay a dividend over the next 12 months.
Over the last 12 months, Teladoc's shares have ranged in value from as little as $26.12 up to $156.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Teladoc's is 0.8566. This would suggest that Teladoc's shares are less volatile than average (for this exchange).
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc.
A simple guide to buying stocks in your favourite European soccer team.
Read more…
Rethink how you grow your money with these green investment strategies and key green stocks.
Read more…
Using our proprietary algorithm, we searched the TSX, NYSE and Nasdaq to find the 10 best penny stocks to buy now.
Read more…Steps to owning and managing NFI stock, with 24-hour and historical pricing before you buy.
Everything we know about the Laser Photonics Corp IPO plus information on how to buy in.
Everything we know about the YanGuFang International Group IPO plus information on how to buy in.
Everything we know about the ParaZero Technologies IPO plus information on how to buy in.
Everything we know about the Li Bang International Corporation IPO plus information on how to buy in.
Everything we know about the Boustead Wavefront IPO plus information on how to buy in.
Everything we know about the NYIAX IPO plus information on how to buy in.
Everything we know about the Adamas One Corp IPO plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO plus information on how to buy in.
